BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23135476)

  • 21. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD133(+) human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis.
    Elkhafif N; El Baz H; Hammam O; Hassan S; Salah F; Mansour W; Mansy S; Yehia H; Zaki A; Magdy R
    APMIS; 2011 Jan; 119(1):66-75. PubMed ID: 21143528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells.
    Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA
    Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Umbilical cord blood cells CD133+/CD133- cultivation in neural proliferation media differentiates towards neural cell lineages.
    Slovinska L; Novotna I; Kubes M; Radonak J; Jergova S; Cigankova V; Rosocha J; Cizkova D
    Arch Med Res; 2011 Oct; 42(7):555-62. PubMed ID: 22015230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cord blood-derived hematopoietic and neural-like stem/progenitor cells are attracted by the neurotransmitter GABA.
    Zangiacomi V; Balon N; Maddens S; Tiberghien P; Versaux-Botteri C; Deschaseaux F
    Stem Cells Dev; 2009 Nov; 18(9):1369-78. PubMed ID: 19327013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs play a role in the development of human hematopoietic stem cells.
    Liao R; Sun J; Zhang L; Lou G; Chen M; Zhou D; Chen Z; Zhang S
    J Cell Biochem; 2008 Jun; 104(3):805-17. PubMed ID: 18189265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF].
    Zhang J; Zhu JS; Li QR; DU Y; Yang B; Li GX; Hu X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):146-50. PubMed ID: 20137136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
    Reems JA; Mielcarek M; Torok-Storb B
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
    Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
    Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-146a and miR-150 promote the differentiation of CD133+ cells into T-lymphoid lineage.
    Fallah P; Arefian E; Naderi M; Aghaee-Bakhtiari SH; Atashi A; Ahmadi K; Shafiee A; Soleimani M
    Mol Biol Rep; 2013 Aug; 40(8):4713-9. PubMed ID: 23673476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells.
    Kekarainen T; Mannelin S; Laine J; Jaatinen T
    BMC Cell Biol; 2006 Aug; 7():30. PubMed ID: 16882340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation.
    Yasui K; Matsumoto K; Hirayama F; Tani Y; Nakano T
    Stem Cells; 2003; 21(2):143-51. PubMed ID: 12634410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of cytokines mediated ex vivo expansion on the cell adhesion molecule expression of cord blood hematopoietic stem and progenitor cells].
    Zhai QL; Qiu LG; Liu Y; Li Q; Han JL; Zhou Z; Li X; Ying HG; Han ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):7-10. PubMed ID: 12905831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients.
    Filip S; Vávrová J; Vokurková D; Bláha M; Vanásek J
    Neoplasma; 2000; 47(2):73-80. PubMed ID: 10985471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.